Applying CIRS-BRAT framework in a regulatory setting: Updated benefit risk assessment for fibrinogen concentrate in the setting of complex cardiac surgery

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2019)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要